Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Equity (2016 - 2025)

Avanos Medical (AVNS) has disclosed Return on Equity for 12 consecutive years, with 0.75% as the latest value for Q3 2025.

  • Quarterly Return on Equity fell 75.0% to 0.75% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.75% through Sep 2025, down 75.0% year-over-year, with the annual reading at 0.01% for FY2024, 4.0% up from the prior year.
  • Return on Equity hit 0.75% in Q3 2025 for Avanos Medical, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.02% in Q4 2022 to a low of 0.75% in Q3 2025.
  • Historically, Return on Equity has averaged 0.07% across 5 years, with a median of 0.02% in 2021.
  • Biggest five-year swings in Return on Equity: grew 7bps in 2024 and later crashed -75bps in 2025.
  • Year by year, Return on Equity stood at 0.02% in 2021, then surged by 180bps to 0.02% in 2022, then plummeted by -316bps to 0.04% in 2023, then surged by 87bps to 0.01% in 2024, then plummeted by -13207bps to 0.75% in 2025.
  • Business Quant data shows Return on Equity for AVNS at 0.75% in Q3 2025, 0.0% in Q2 2025, and 0.07% in Q1 2025.